Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid Tumor Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05708950
What this trial is testing

A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)

Who this might be right for
CancerSolid TumorMelanoma+14 more
Kineta Inc. 40
Not applicableLooking for participantsNCT07584824
What this trial is testing

Is the 1939 Cancer Act Fit for Purpose in the Modern Technology Era?

Who this might be right for
CancerCancer (Active Cancer, Meaning Not Being Cancer Free), of Any Stage and Involving Any Treatment/Care Regimen; i.e. Curative, Life-extending, or PalliativeCancer (Solid Tumors)+2 more
Royal Cornwall Hospitals Trust 50
Early research (Phase 1)Study completedNCT01928459
What this trial is testing

Phase 1b Trial of BGJ398/BYL719 in Solid Tumors

Who this might be right for
Advanced Solid TumorsMetastatic Solid Tumors
Novartis Pharmaceuticals 62
Early research (Phase 1)Looking for participantsNCT06426680
What this trial is testing

The ILB-3101 in Patients with Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Innolake Biopharm 240
Not applicableLooking for participantsNCT06073938
What this trial is testing

Compassionate Use Study of NHWD-870 in Patients With Advanced Solid Tumors or Lymphomas Carrying NUT Rearrangement

Who this might be right for
Advanced Solid Tumors or Lymphomas
Hunan Province Tumor Hospital 30
Early research (Phase 1)Study completedNCT01139723
What this trial is testing

The Safety and Pharmacokinetics of MINT1526A, Administered Intravenously As a Single Agent and in Combination With Bevacizumab to Patients With Advanced Solid Tumors

Who this might be right for
Solid Cancers
Genentech, Inc. 54
Testing effectiveness (Phase 2)Study completedNCT02280317
What this trial is testing

Dose Finding Safety Study of VAL201 in Cancer Patients

Who this might be right for
Stage III Prostate CarcinomaStage IV Prostate Carcinoma
ValiRx Plc 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT06730750
What this trial is testing

BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bristol-Myers Squibb 360
Early research (Phase 1)Ended earlyNCT03685591
What this trial is testing

PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors

Who this might be right for
Breast NeoplasmsProstate NeoplasmsNeoplasms, Squamous Cell+6 more
Pfizer 49
Not applicableNot Yet RecruitingNCT06090513
What this trial is testing

Molecular Services and EMR-Lab Integration Application (ELIA) for Reducing Healthcare Disparities in Cancer Patients

Who this might be right for
Advanced CancerSolid Tumor, AdultMyeloid Malignancy
Bien-Willner Physicians Group PA 300
Early research (Phase 1)UnknownNCT04678908
What this trial is testing

Injection HB0025 in Patients With Advanced Solid Tumors

Who this might be right for
Tumor, Subjects
Huabo Biopharm Co., Ltd. 154
Testing effectiveness (Phase 2)Study completedNCT02805725
What this trial is testing

Targeting Microenvironment and Cellular Immunity in Sarcomas Weekly Trabectedin Combined With Metronomic Cyclophosphamide

Who this might be right for
Soft-tissue Sarcomas
Institut Bergonié 50
Early research (Phase 1)Study completedNCT03335540
What this trial is testing

An Adaptive Study to Match Patients With Solid Tumors to Various Immunotherapy Combinations Based Upon a Broad Biomarker Assessment

Who this might be right for
Advanced Cancer
Bristol-Myers Squibb 20
Early research (Phase 1)Active Not RecruitingNCT06005740
What this trial is testing

A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer

Who this might be right for
Advanced Solid TumorHepatocellular Carcinoma
TORL Biotherapeutics, LLC 70
Early research (Phase 1)Study completedNCT02159989
What this trial is testing

Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmFibrolamellar CarcinomaMetastatic Malignant Solid Neoplasm+5 more
National Cancer Institute (NCI) 83
Early research (Phase 1)WithdrawnNCT01437280
What this trial is testing

GOAT; Phase I Open Label Study of CGTG-102, a GM-CSF Encoding Oncolytic Adenovirus, for Advanced Cancers

Who this might be right for
TumorsSolid Tumors
Baylor College of Medicine
Early research (Phase 1)Ended earlyNCT05338346
What this trial is testing

ATG-018 (ATR Inhibitor) Treatment in Patients With Advanced Solid Tumors and Hematological Malignancies

Who this might be right for
Advanced Solid TumorsHematological Malignancies
Antengene Discovery Limited 22
Early research (Phase 1)Study completedNCT02526017
What this trial is testing

Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers

Who this might be right for
Advanced Solid TumorsHead and Neck CancerPancreatic Cancer+4 more
Five Prime Therapeutics, Inc. 313
Early research (Phase 1)Study completedNCT00674024
What this trial is testing

Pazopanib to Treat Adults With Advanced Cancers and Varying Degrees of Liver Function

Who this might be right for
NeoplasmsLymphoma
National Cancer Institute (NCI) 8
Not applicableStudy completedNCT02080650
What this trial is testing

Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)

Who this might be right for
Prostate CancerRenal Cell CarcinomaBladder Cancer+5 more
Duke University 62
Next Page